Development of a New Patient-Reported Outcome Measure in Sarcopenia

Christopher J. Evans, Chiun Fang Chiou, Kristina A. Fitzgerald, William J. Evans, Betty Ferrell, William Dale, Linda P Fried, Shravanthi R. Gandra, Brooke Dennee-Sommers, Donald L. Patrick

Research output: Contribution to journalArticle

Abstract

Objective: The objective of this study was to develop a patient-reported outcome (PRO) to assess reduced muscle strength in sarcopenia. Design: Qualitative research study. Setting: University of Arkansas for Medical Sciences. Participants: Subjects with sarcopenia. Measurements: Adults aged 55 years and older with sarcopenia (n = 12) attended open-ended, concept elicitation interviews to characterize the functional effects of reduced muscle strength on their lives. The resulting qualitative data were analyzed using a qualitative analysis software program (Atlas.ti [Atlas.ti GmbH, Berlin, Germany]) and a common set of codes was developed to summarize the data. Subsequently, the initial PRO measure was drafted. Cognitive interviews were then conducted with additional sarcopenia subjects (n = 12) to refine the measure. Results: Qualitative interviews identified key concepts (eg, impacts) in the areas of activities of daily living, emotions, social activities, energy, balance, coordination, sleep, and strength. Based on data from the cognitive debriefing interviews (eg, understandability, relevance, suggestions to reword items), the PRO measure development team came to consensus on which items or parts of the instructions to retain, revise, or delete. The final measure included 14 items. Conclusion: The final PRO measure, the Age-Related Muscle Loss Questionnaire, can be used in both clinical practice and clinical trial settings to assess functional impacts of reduced muscle strength in sarcopenia.

Original languageEnglish (US)
Pages (from-to)226-233
Number of pages8
JournalJournal of the American Medical Directors Association
Volume12
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Sarcopenia
Muscle Strength
Interviews
Atlases
Qualitative Research
Berlin
Activities of Daily Living
Germany
Consensus
Sleep
Emotions
Software
Patient Reported Outcome Measures
Clinical Trials
Muscles

Keywords

  • Muscle wasting
  • Patient-reported outcome
  • Sarcopenia

ASJC Scopus subject areas

  • Medicine(all)
  • Nursing(all)
  • Health Policy

Cite this

Evans, C. J., Chiou, C. F., Fitzgerald, K. A., Evans, W. J., Ferrell, B., Dale, W., ... Patrick, D. L. (2011). Development of a New Patient-Reported Outcome Measure in Sarcopenia. Journal of the American Medical Directors Association, 12(3), 226-233. https://doi.org/10.1016/j.jamda.2010.09.010

Development of a New Patient-Reported Outcome Measure in Sarcopenia. / Evans, Christopher J.; Chiou, Chiun Fang; Fitzgerald, Kristina A.; Evans, William J.; Ferrell, Betty; Dale, William; Fried, Linda P; Gandra, Shravanthi R.; Dennee-Sommers, Brooke; Patrick, Donald L.

In: Journal of the American Medical Directors Association, Vol. 12, No. 3, 03.2011, p. 226-233.

Research output: Contribution to journalArticle

Evans, CJ, Chiou, CF, Fitzgerald, KA, Evans, WJ, Ferrell, B, Dale, W, Fried, LP, Gandra, SR, Dennee-Sommers, B & Patrick, DL 2011, 'Development of a New Patient-Reported Outcome Measure in Sarcopenia', Journal of the American Medical Directors Association, vol. 12, no. 3, pp. 226-233. https://doi.org/10.1016/j.jamda.2010.09.010
Evans, Christopher J. ; Chiou, Chiun Fang ; Fitzgerald, Kristina A. ; Evans, William J. ; Ferrell, Betty ; Dale, William ; Fried, Linda P ; Gandra, Shravanthi R. ; Dennee-Sommers, Brooke ; Patrick, Donald L. / Development of a New Patient-Reported Outcome Measure in Sarcopenia. In: Journal of the American Medical Directors Association. 2011 ; Vol. 12, No. 3. pp. 226-233.
@article{e7c842ce5cfe4aa7a8ec3163ba2fd75c,
title = "Development of a New Patient-Reported Outcome Measure in Sarcopenia",
abstract = "Objective: The objective of this study was to develop a patient-reported outcome (PRO) to assess reduced muscle strength in sarcopenia. Design: Qualitative research study. Setting: University of Arkansas for Medical Sciences. Participants: Subjects with sarcopenia. Measurements: Adults aged 55 years and older with sarcopenia (n = 12) attended open-ended, concept elicitation interviews to characterize the functional effects of reduced muscle strength on their lives. The resulting qualitative data were analyzed using a qualitative analysis software program (Atlas.ti [Atlas.ti GmbH, Berlin, Germany]) and a common set of codes was developed to summarize the data. Subsequently, the initial PRO measure was drafted. Cognitive interviews were then conducted with additional sarcopenia subjects (n = 12) to refine the measure. Results: Qualitative interviews identified key concepts (eg, impacts) in the areas of activities of daily living, emotions, social activities, energy, balance, coordination, sleep, and strength. Based on data from the cognitive debriefing interviews (eg, understandability, relevance, suggestions to reword items), the PRO measure development team came to consensus on which items or parts of the instructions to retain, revise, or delete. The final measure included 14 items. Conclusion: The final PRO measure, the Age-Related Muscle Loss Questionnaire, can be used in both clinical practice and clinical trial settings to assess functional impacts of reduced muscle strength in sarcopenia.",
keywords = "Muscle wasting, Patient-reported outcome, Sarcopenia",
author = "Evans, {Christopher J.} and Chiou, {Chiun Fang} and Fitzgerald, {Kristina A.} and Evans, {William J.} and Betty Ferrell and William Dale and Fried, {Linda P} and Gandra, {Shravanthi R.} and Brooke Dennee-Sommers and Patrick, {Donald L.}",
year = "2011",
month = "3",
doi = "10.1016/j.jamda.2010.09.010",
language = "English (US)",
volume = "12",
pages = "226--233",
journal = "Journal of the American Medical Directors Association",
issn = "1525-8610",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Development of a New Patient-Reported Outcome Measure in Sarcopenia

AU - Evans, Christopher J.

AU - Chiou, Chiun Fang

AU - Fitzgerald, Kristina A.

AU - Evans, William J.

AU - Ferrell, Betty

AU - Dale, William

AU - Fried, Linda P

AU - Gandra, Shravanthi R.

AU - Dennee-Sommers, Brooke

AU - Patrick, Donald L.

PY - 2011/3

Y1 - 2011/3

N2 - Objective: The objective of this study was to develop a patient-reported outcome (PRO) to assess reduced muscle strength in sarcopenia. Design: Qualitative research study. Setting: University of Arkansas for Medical Sciences. Participants: Subjects with sarcopenia. Measurements: Adults aged 55 years and older with sarcopenia (n = 12) attended open-ended, concept elicitation interviews to characterize the functional effects of reduced muscle strength on their lives. The resulting qualitative data were analyzed using a qualitative analysis software program (Atlas.ti [Atlas.ti GmbH, Berlin, Germany]) and a common set of codes was developed to summarize the data. Subsequently, the initial PRO measure was drafted. Cognitive interviews were then conducted with additional sarcopenia subjects (n = 12) to refine the measure. Results: Qualitative interviews identified key concepts (eg, impacts) in the areas of activities of daily living, emotions, social activities, energy, balance, coordination, sleep, and strength. Based on data from the cognitive debriefing interviews (eg, understandability, relevance, suggestions to reword items), the PRO measure development team came to consensus on which items or parts of the instructions to retain, revise, or delete. The final measure included 14 items. Conclusion: The final PRO measure, the Age-Related Muscle Loss Questionnaire, can be used in both clinical practice and clinical trial settings to assess functional impacts of reduced muscle strength in sarcopenia.

AB - Objective: The objective of this study was to develop a patient-reported outcome (PRO) to assess reduced muscle strength in sarcopenia. Design: Qualitative research study. Setting: University of Arkansas for Medical Sciences. Participants: Subjects with sarcopenia. Measurements: Adults aged 55 years and older with sarcopenia (n = 12) attended open-ended, concept elicitation interviews to characterize the functional effects of reduced muscle strength on their lives. The resulting qualitative data were analyzed using a qualitative analysis software program (Atlas.ti [Atlas.ti GmbH, Berlin, Germany]) and a common set of codes was developed to summarize the data. Subsequently, the initial PRO measure was drafted. Cognitive interviews were then conducted with additional sarcopenia subjects (n = 12) to refine the measure. Results: Qualitative interviews identified key concepts (eg, impacts) in the areas of activities of daily living, emotions, social activities, energy, balance, coordination, sleep, and strength. Based on data from the cognitive debriefing interviews (eg, understandability, relevance, suggestions to reword items), the PRO measure development team came to consensus on which items or parts of the instructions to retain, revise, or delete. The final measure included 14 items. Conclusion: The final PRO measure, the Age-Related Muscle Loss Questionnaire, can be used in both clinical practice and clinical trial settings to assess functional impacts of reduced muscle strength in sarcopenia.

KW - Muscle wasting

KW - Patient-reported outcome

KW - Sarcopenia

UR - http://www.scopus.com/inward/record.url?scp=79951656300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951656300&partnerID=8YFLogxK

U2 - 10.1016/j.jamda.2010.09.010

DO - 10.1016/j.jamda.2010.09.010

M3 - Article

C2 - 21333926

AN - SCOPUS:79951656300

VL - 12

SP - 226

EP - 233

JO - Journal of the American Medical Directors Association

JF - Journal of the American Medical Directors Association

SN - 1525-8610

IS - 3

ER -